[(4R)-2-oxopentadecan-4-yl] dodecanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: [(4R)-2-oxopentadecan-4-yl] dodecanoate
• 化学式: C₂₇H₅₂O₃
• 分子量: 424.7
• InChiKey: UITKHKDKGDPDGL-AREMUKBSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  10.6
• 重原子数：
  30
• 可旋转键数：
  24
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF
  申请人：VARIATION BIOTECHNOLOGIES INC.

  公开号：US20140328876A1

  公开（公告）日：2014-11-06

  In one aspect, the present disclosure provides compounds of formulae (I) and (II). In another aspect, a compound of formula (I) or (II) is formulated into compositions with an antigen, optionally with a vesicle. In some embodiments, compositions are administered intramuscularly.

  在一个方面，本公开提供了式(I)和(II)的化合物。在另一个方面，将式(I)或(II)的化合物与抗原配制成组合物，可选地与囊泡一起。在一些实施方式中，这些组合物是肌肉注射给药的。
• IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO AN OVERPRODUCTION OF INFLAMMATORY CYTOKINES
  申请人：Bauer Jacques

  公开号：US20090054378A1

  公开（公告）日：2009-02-26

  Method of using immunomodulatory compounds for treating diseases related to an overproduction of inflammatory cytokines, including diseases selected from asthma, atopic dermatitis, allergic rhinitis, prostatitis, inflammatory bowel disease, diabetes, and rhumatoid arthritis, the compounds being of general formula (I): wherein: m and n, independently from each other, are an integer ranging from 1 to 4, X and Y represent —COOH, —O—P(O)(OH) 2 , —O—SO 2 (OH), —NH 2 , —OH, —CONH(CH 2 ) n1 —NH 2 , —CO—NH—CH(COOH)—(CH 2 ) n1 —COOH, —CO—NH—CH(COOH)—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —CHOH—CH 2 OH, —O—CO—(CH 2 ) n1 —OH, O—CO—(CH 2 ) n1 —COOH, —O—CO—(CH 2 ) n1 —CHO, —O—CO—(CH 2 ) n1 —NH—CO—(CH 2 ) n2 —COOH, R 1 and R 2 each designate an acyl group derived from a saturated or unsaturated, straight- or branched-chain carboxylic acid having from 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl, dihydroxyphosphoryloxy, alkyl of 2 to 10 carbon atoms, alkoxy of 2 to 10 carbon atoms, acyloxy of 2 to 18 carbon atoms in the acyl moiety, amino, acylamino.

  使用免疫调节化合物治疗与炎症细胞因子过度产生相关的疾病的方法，包括从哮喘、特应性皮炎、过敏性鼻炎、前列腺炎、炎症性肠病、糖尿病和类风湿关节炎中选择的疾病，所述化合物具有通式(I)：其中：m和n分别独立于彼此，为1至4之间的整数，X和Y代表—COOH，—O—P(O)(OH)2，—O—SO2(OH)，—NH2，—OH，—CONH(CH2)n1—NH2，—CO—NH—CH(COOH)—( )n1—COOH，—CO—NH—CH(COOH)—( )n1—NH2，—O—CO—( )n1—NH2，—O—CO—( )n1—CHOH— OH，—O—CO—( )n1—OH，O—CO—( )n1—COOH，—O—CO—( )n1—CHO，—O—CO—( )n1—NH—CO—( )n2—COOH，R1和R2各自指代从饱和或不饱和、直链或支链的具有2至18个碳原子的羧酸衍生的酰基，该酰基未取代或带有1到3个在2到10个碳原子的烷基、2到10个碳原子的烷氧基、2到18个碳原子的酰氧基在酰基部分、氨基、酰氨基中选择的取代基。
• US7915240B2
  申请人：——

  公开号：US7915240B2

  公开（公告）日：2011-03-29